Al-Ghamdi Hasen A, Al Fayez Fayza F, Bima Abdulhadi I, Khawaji Taghreed M, Elsamanoudy Ayman Z
Clinical Biochemistry, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Medical Biochemistry and Molecular Biology, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
J Clin Exp Hepatol. 2021 Mar-Apr;11(2):219-226. doi: 10.1016/j.jceh.2020.07.003. Epub 2020 Jul 18.
Nonalcoholic fatty liver disease (NAFLD) is a pathological process characterized by excessive hepatic fatty deposition with possible involvement of vitamin D deficiency and cellular senescence. The aim of this study is to investigate the pathophysiologic role of vitamin D deficiency and cellular senescence in NAFLD development. Moreover, it aims to investigate the potential protective role of vitamin D supplementation.
This is an experimental Case/Control study. Forty-five male albino rats were enrolled in this study. Animals were divided into four groups: negative and positive control groups (10 for each group), a model of NAFLD (11) and vitamin D-treated NAFLD groups (14). At the end of the experiment, all rats were subjected to the following investigation; biochemical estimation of serum 25 hydroxycholecalciferol, senescence marker protein-30 (SMP-30), lipid profile and calculation of homeostatic model of insulin resistance (HOMA-IR).
NAFLD group shows a significant increase in glucose, insulin levels, and HOMA- IR compared with both normal controls. This finding indicates the intimate association between insulin resistance and NAFLD pathogenesis. Moreover, it was found that NAFLD group shows a significant decrease in SMP-30 level compared with normal controls. While vitamin D-treated NAFLD group shows significant increased SMP-30 and decrease in HOMA-IR in comparison with nontreated NAFLD group.
Vitamin D deficiency and increased cellular senescence are key features of NAFLD. Vitamin D supplementation could play a protective role, which needs further investigation including clinical human study.
非酒精性脂肪性肝病(NAFLD)是一种以肝脏脂肪过度沉积为特征的病理过程,可能与维生素D缺乏和细胞衰老有关。本研究的目的是探讨维生素D缺乏和细胞衰老在NAFLD发生发展中的病理生理作用。此外,旨在研究补充维生素D的潜在保护作用。
这是一项实验性病例/对照研究。45只雄性白化大鼠参与本研究。动物被分为四组:阴性和阳性对照组(每组10只)、NAFLD模型组(11只)和维生素D治疗的NAFLD组(14只)。实验结束时,所有大鼠接受以下检查;血清25羟胆钙化醇、衰老标记蛋白-30(SMP-30)、血脂谱的生化测定以及胰岛素抵抗稳态模型(HOMA-IR)的计算。
与正常对照组相比,NAFLD组的血糖、胰岛素水平和HOMA-IR显著升高。这一发现表明胰岛素抵抗与NAFLD发病机制密切相关。此外,发现与正常对照组相比,NAFLD组的SMP-30水平显著降低。与未治疗的NAFLD组相比,维生素D治疗的NAFLD组的SMP-30显著升高,HOMA-IR降低。
维生素D缺乏和细胞衰老增加是NAFLD的关键特征。补充维生素D可能起到保护作用,这需要进一步研究,包括临床人体研究。